Live Breaking News & Updates on While core one labs inc

Stay informed with the latest breaking news from While core one labs inc on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in While core one labs inc and stay connected to the pulse of your community

Core One's Vocan Biotechnologies Incorporates New Bioreactor Equipment into Production Process Significantly Increasing Throughput of Proprietary Biosynthetic Psilocybin

Core One's Vocan Biotechnologies Incorporates New Bioreactor Equipment into Production Process Significantly Increasing Throughput of Proprietary Biosynthetic Psilocybin
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Vancouver , British-columbia , Canada , Canadian , Joel-shacker , Core-one-labs-inc , Vocan-biotechnologies-inc , Health-canada , Canadian-securities-exchange , While-core-one-labs-inc , Core-one-labs , Vocan-biotechnologies

Core One's Vocan Biotechnologies Incorporates New Bioreactor Equipment ...

Core One's Vocan Biotechnologies Incorporates New Bioreactor Equipment ...
pr-inside.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pr-inside.com Daily Mail and Mail on Sunday newspapers.

Vancouver , British-columbia , Canada , Canadian , Joel-shacker , While-core-one-labs-inc , Canadian-securities-exchange , Core-one-labs-inc , Vocan-biotechnologies-inc , News-network , Health-canada , Core-one-labs

Core One Labs Inc.: Core One's Vocan Biotechnologies Incorporates New Bioreactor Equipment into Production Process Significantly Increasing Throughput of Proprietary Biosynthetic Psilocybin

Core One Labs Inc.: Core One's Vocan Biotechnologies Incorporates New Bioreactor Equipment into Production Process Significantly Increasing Throughput of Proprietary Biosynthetic Psilocybin
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Vancouver , British-columbia , Canada , Canadian , Joel-shacker , While-core-one-labs-inc , Vocan-biotechnologies-inc , Canadian-securities-exchange , Health-canada , Core-one-labs-inc , Core-one-labs-inc-view , Core-one-labs

Core One Labs Inc.: Core One Labs Engages Donohoe Advisory for Nasdaq Listing and Schedules Special Investor Call with Dr. Robert E.W. Hancock to Demonstrate Recent Research Outcome

(6)
VANCOUVER, BC / ACCESSWIRE / February 6, 2021 / Core One Labs Inc. (CSE:COOL)(OTC PINK:CLABF)(Frankfurt:LD62)(WKN:A2P8K3) (the "Company") announces that it has engaged Donohoe Advisory Associates LLC ("Donohoe Advisory") in connection with its efforts to seek a listing for its common shares on a NASDAQ Stock Market. The Company expects that listing its common shares on NASDAQ will provide increased investor awareness and market liquidity for shareholders.
Donohoe Advisory was founded by Dave Donohoe in 2004, and since that time the firm has successfully represented hundreds of companies in a wide range of listing matters for both the NASDAQ Stock Market and the New York Stock Exchange. Donohoe's senior advisory team have previously worked for either NASDAQ or the New York Stock Exchange (NYSE). Prior to forming Donohoe Advisory, Dave Donohoe spent over nine years with NASDAQ, where he ultimately served as Chief Counsel in the Listing Qualifications Department. Other senior advisors include Katherine Roberson Petty, former Senior Counsel for NASDAQ's Office of General Counsel, Bruce Poignant, former NYSE Executive in their Capital Markets Group, Tamara Kondic, former Director in the Listing Qualifications Department at the Nasdaq Stock Market LLC, and David Compton, former Director of Corporate Governance Interpretations at NASDAQ.

Germany , Canada , United-kingdom , Vancouver , British-columbia , British , Canadian , Robertew-hancock , Tamara-kondic , Dave-donohoe , David-compton , Joel-shacker

Core One Labs Engages Donohoe Advisory for Nasdaq Listing and Schedules Special Investor Call with Dr. Robert E.W. Hancock to Demonstrate Recent Research Outcome

Core One Labs Engages Donohoe Advisory for Nasdaq Listing and Schedules Special Investor Call with Dr. Robert E.W. Hancock to Demonstrate Recent Research Outcome
pittsburghstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pittsburghstar.com Daily Mail and Mail on Sunday newspapers.

Germany , Canada , United-kingdom , Vancouver , British-columbia , British , Canadian , Robertew-hancock , Tamara-kondic , Dave-donohoe , David-compton , Joel-shacker

Core One Labs Inc.: Core One Labs Announces Its Entrance into the Ketamine Space with Proposed Acquisition of Ketamine Infusion Centers of Texas

Core One Labs Inc.: Core One Labs Announces Its Entrance into the Ketamine Space with Proposed Acquisition of Ketamine Infusion Centers of Texas
Core One Labs Inc. (CSE:COOL)(OTC PINK:CLABF)(Frankfurt:LD62) (WKN: A2P8K3) (the "
Company") a biotechnology research and development company focused in life sciences and on bringing psychedelic medicines to market through novel delivery systems and psychedelic assisted psychotherapy is pleased to announce it has entered into a letter of intent (the "
Letter of Intent") dated January 20, 2021 with Ketamine Infusion Centers of Texas, LLC ("
KICT"), an arms-length-party, to review a potential acquisition of KICT.

United-states , Canada , Texas , Vancouver , British-columbia , Americans , America , Canadian , Joel-shaker , Thomas-insel , Michael-nguyen , Joel-shacker

Core One Labs Announces Its Entrance into the Ketamine Space with Proposed Acquisition of Ketamine Infusion Centers of Texas

Press release content from Accesswire. The AP news staff was not involved in its creation.
Core One Labs Announces Its Entrance into the Ketamine Space with Proposed Acquisition of Ketamine Infusion Centers of Texas
February 4, 2021 GMT
VANCOUVER, BC / ACCESSWIRE / February 4, 2021 / Core One Labs Inc. (CSE:COOL)(OTC PINK:CLABF)(Frankfurt:LD62) (WKN: A2P8K3) (the “Company”) a biotechnology research and development company focused in life sciences and on bringing psychedelic medicines to market through novel delivery systems and psychedelic assisted psychotherapy is pleased to announce it has entered into a letter of intent (the “Letter of Intent”) dated January 20, 2021 with Ketamine Infusion Centers of Texas, LLC (“KICT”), an arms-length-party, to review a potential acquisition of KICT.

United-states , Canada , Texas , Vancouver , British-columbia , Americans , America , Canadian , Joel-shaker , Thomas-insel , Michael-nguyen , Joel-shacker

Core One Labs Announces Vocan Assembles Equipment to Produce Biosynthesized Psilocybin

Core One Labs Announces Vocan Assembles Equipment to Produce Biosynthesized Psilocybin
saltlakecitysun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from saltlakecitysun.com Daily Mail and Mail on Sunday newspapers.

Canada , Vancouver , British-columbia , Canadian , Joel-shacker , Core-one-labs-inc , Vocan-biotechnologies-inc , Health-canada , Canadian-securities-exchange , While-core-one-labs-inc , Core-one-labs , Vocan-biotechnologies

Core One Labs Inc.: Core One Labs Announces Vocan Assembles Equipment to Produce Biosynthesized Psilocybin

Core One Labs Inc.: Core One Labs Announces Vocan Assembles Equipment to Produce Biosynthesized Psilocybin
Core One Labs Inc. (CSE:COOL)(OTC PINK:CLABF)(Frankfurt:LD62)(WKN:A2P8K3) (the "
Company") is pleased to announce its wholly-owned subsidiary Vocan Biotechnologies Inc. ("
Vocan") has assembled the necessary equipment, which will allow the laboratory to commence the process of recombinant production of psilocybin. The process that engineers bacteria incorporating optimized biosynthetic genes from the
Psilocybe cubensis mushroom, will enable the bacteria to act as a biological factory and synthesize psilocybin that is cost effective using simple building blocks.
Vocan's platform can make the active compounds that occur naturally, by using a gene mimicry process and simple chemical modifications to enable the creation of bioidentical compounds as well as known and novel analogs. The analog compounds could prove to be more effective, targeted and safer.

Canada , Vancouver , British-columbia , Canadian , Joel-shacker , Core-one-labs-inc , Vocan-biotechnologies-inc , Health-canada , Canadian-securities-exchange , While-core-one-labs-inc , Core-one-labs , Vocan-biotechnologies

Core One Labs Completes Sale of Non-Core Assets

Core One Labs Completes Sale of Non-Core Assets
phoenixherald.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from phoenixherald.com Daily Mail and Mail on Sunday newspapers.

California , United-states , Nevada , Canada , Vancouver , British-columbia , Adelanto , Canadian , Joel-shacker , Holdings-inc , Development-corporation-devco , Reveur-holdings-inc